Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Manitoba

$29,000.00

Monoterpene indole alkaloid gene discovery and evolution in the Apocynaceae

FY 2019-20

Summary
Collectively, plants produce over 400k natural products that they use for development and defence. Many of these compounds interact with human biological functions, and thus may serve as pharmaceutical agents. Given the high number of plant-derived natural products, a large number of plant natural products have not been tested for efficacy as potential drugs.***     *The natural products used as drugs are particularly abundant in certain plant families. For example, the Dogbane (Apocynaceae) and related plant families produce over 3000 monoterpene indole alkaloids (MIAs). Catharanthus roseus accumulates vinblastine and vincristine, which are used as chemotherapeutic drugs to combat a number of cancers. Recent genomics studies identified many of the genes and enzymes that produce these drugs. In this study, I will utilize these resources to develop a gene capture array that will be used to isolate DNA fragments that encode MIA biosynthetic genes. This array will then be used to capture new genes from other species that produce medicinal MIAs, and I will sequence these genes using next-generation sequencing techniques.***     I will focus on the plant Tabernanthe iboga (iboga), which accumulates MIAs in its roots in quantities up to 6% by weight. Two of these alkaloids, coronaridine and ibogaine, have potential to treat opiate addictions. My laboratory will perform experiments to identify, clone and characterize the MIA biosynthetic genes and encoded enzymes that produce these compounds. We will concurrently develop an iboga `hairy root' cell culture system. Using this system, we can introduce DNA fragments that we wish to be transferred and incorporated into the iboga genome. We will add DNA sequences to reduce the expression of the genes that produce the iboga alkaloids. A long term plan is to introduce the new MIA-biosynthetic genes that were identified from the gene capture experiments to screen for new biosynthetic capabilities.***     *These experiments will expand our knowledge of the diversity in MIA biosynthetic genes and enzymes. The development of the engineered iboga hairy root cultures has the potential to produce a myriad of novel MIAs which will be made available to pharmacologists for activity screening. Optimization of MIA biosynthesis in the hairy root culture system may allow for scaled-up production of these compounds. A future goal is to produce vinblastine and vincristine in this system, which will result in a sustainable supply of these drugs at a potentially lower cost compared to their extraction from C. roseus plants.**
Program
Discovery Grants Program - Individual
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2015-05151
Name nom
Stout, Jake
Department département
Biological Sciences
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2015
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
4901
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Nutrition and metabolism, photosynthesis
Research subject fr
Nutrition et métabolisme, photosynthèse
Installment
inst:5 - 6
Partie
5
Nb partie
6
Application title
Monoterpene indole alkaloid gene discovery and evolution in the Apocynaceae
Keyword
NSERC
Application summary
Collectively, plants produce over 400k natural products that they use for development and defence. Many of these compounds interact with human biological functions, and thus may serve as pharmaceutical agents. Given the high number of plant-derived natural products, a large number of plant natural products have not been tested for efficacy as potential drugs.***     *The natural products used as drugs are particularly abundant in certain plant families. For example, the Dogbane (Apocynaceae) and related plant families produce over 3000 monoterpene indole alkaloids (MIAs). Catharanthus roseus accumulates vinblastine and vincristine, which are used as chemotherapeutic drugs to combat a number of cancers. Recent genomics studies identified many of the genes and enzymes that produce these drugs. In this study, I will utilize these resources to develop a gene capture array that will be used to isolate DNA fragments that encode MIA biosynthetic genes. This array will then be used to capture new genes from other species that produce medicinal MIAs, and I will sequence these genes using next-generation sequencing techniques.***     I will focus on the plant Tabernanthe iboga (iboga), which accumulates MIAs in its roots in quantities up to 6% by weight. Two of these alkaloids, coronaridine and ibogaine, have potential to treat opiate addictions. My laboratory will perform experiments to identify, clone and characterize the MIA biosynthetic genes and encoded enzymes that produce these compounds. We will concurrently develop an iboga `hairy root' cell culture system. Using this system, we can introduce DNA fragments that we wish to be transferred and incorporated into the iboga genome. We will add DNA sequences to reduce the expression of the genes that produce the iboga alkaloids. A long term plan is to introduce the new MIA-biosynthetic genes that were identified from the gene capture experiments to screen for new biosynthetic capabilities.***     *These experiments will expand our knowledge of the diversity in MIA biosynthetic genes and enzymes. The development of the engineered iboga hairy root cultures has the potential to produce a myriad of novel MIAs which will be made available to pharmacologists for activity screening. Optimization of MIA biosynthesis in the hairy root culture system may allow for scaled-up production of these compounds. A future goal is to produce vinblastine and vincristine in this system, which will result in a sustainable supply of these drugs at a potentially lower cost compared to their extraction from C. roseus plants.**